spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cardiokine 

 HSMN NewsFeed - 26 Apr 2018
Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Dec 2014
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 15 Apr 2014
AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 6 Jan 2014
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
Devices Surgery Radiology Personnel
 HSMN NewsFeed - 14 Oct 2013
CardioKinetix Announces First Heart Failure Patients Treated in China With Novel Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Aug 2013
CardioKinetix Announces First Heart Failure Patients Treated in Asia with Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jun 2013
Cerecor Appoints Federica F. O’Brien as Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Oct 2012
CardioKinetix Announces Data From Latest European Study of Heart Failure Patients With First-of-Its-Kind Percutaneous Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
CardioKinetix Receives CE Mark Approval for Full Range of Sizes for First-of-Its-Kind Percutaneous Treatment for Heart Failure
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Jun 2012
CardioKinetix Initiates European Post-Market Trial of First-of-Its-Kind Minimally Invasive Treatment for Heart Failure in Germany
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2012
CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
CardioKinetix Announces Late Breaking EuroPCR Session Featuring First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
Maria Sainz Joins CardioKinetix as President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 30 Jan 2012
CardioKinetix Receives Expanded CE Mark Approval for World's First Percutaneous Left Ventricular Partitioning Device, the Parachute(TM), for Treatment of Ischemic Heart Failure
Devices Cardiology Regulatory
 HSMN NewsFeed - 5 Jan 2012
First Patients in Portugal, Latvia, Slovenia, and the United Kingdom Treated With CardioKinetix's Parachute(TM) Ventricular Partitioning Device
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2012
Cornerstone Therapeutics Acquires Cardiokine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2011
CardioKinetix Inc. Raises $44 Million in Series E Financing
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 7 Oct 2009
Amber Salzman Named President and CEO of Cardiokine
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2008
Biogen Idec and Cardiokine Initiate Phase III Clinical Trial for Lixivaptan in Congestive Heart Failure Patients with Hyponatremia
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Jan 2008
Dr. Manuel Worcel Appointed CEO and President of Cardiokine
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2007
CEO and President David Brand to Leave Cardiokine
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2007
Inotek Pharmaceuticals Announces Additions to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2007
4-Antibody AG Closes CHF 17 Million Series A Financing, Bringing the Total Series A Financing to CHF 23 Million ($ 18.5Million)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2006
NeoGuide Systems Closes Series C Financing
Devices Venture Capital
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.